Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Date
2022-08-23
Keywords
Stem cell; Hematotoxicity; T-cell
Bibliographic citation
Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Bücklein V, et al. Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood Adv. 2022 Aug 23;6(16):4719-25.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/9612This item appears in following collections
- HVH - Articles científics [2476]
- VHIO - Articles científics [737]
The following license files are associated with this item:
